This retrospective analysis of 46 phenotypically well-defined SSc patient before and after AHSCT was focused on the genetic and/or the circulating expression of two potent immuno-modulatory molecules namely HLA-E and HLA-G, and their potential influence on clinical response. Here, HLA-E is linked to systemic sclerosis.